First-pass extracted concept

FasL-Fas signaling

Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

CD95 signaling, Fas signaling

Extracted Explainers

What the tool is doing

FasL-Fas signaling is presented as a death ligand/receptor signaling system active in the central nervous system. The abstract states that it has functional relevance across neurological disease models and also includes non-apoptotic signaling outputs.

Source 1DOIPubMed

What problem it solves

It helps organize interpretation of how extrinsic death receptor signaling contributes to CNS disease and neuroplasticity.

Source 1DOIPubMed

What it does not solve

The abstract does not present FasL-Fas signaling itself as a discrete intervention, assay, or engineered construct.

Source 1DOIPubMed

Alternatives

The abstract contrasts extrinsic death receptor-induced signaling with intrinsic mitochondrial-mediated apoptotic signaling.

Source 1DOIPubMed

Evidence Snippets

This review summarizes the functional relevance of FasL-Fas signaling--a quintessential death ligand/receptor system--in different neurological disease models
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1functional rolesupports2008Source 1DOIPubMed

The paper outlines alternative non-apoptotic Fas signaling and presents it as having neuroplastic capacity.

Claim 2mechanistic interpretationsupports2008Source 1DOIPubMed

In the central nervous system, intrinsic mitochondrial-mediated apoptotic signaling reflects a cell's individual metabolic stress, whereas activation of the extrinsic death receptor-induced cascade is regarded as a sign of imbalanced cellular networks.

Claim 3physiological observationsupports2008Source 1DOIPubMed

Under physiological conditions, most neurons possess death receptors without being sensitive to receptor-mediated apoptosis.

Claim 4review scopesupports2008Source 1DOIPubMed

The paper summarizes the functional relevance of FasL-Fas signaling across traumatic, inflammatory, ischemic, and neurodegenerative neurological disease models.